Fennec Pharmaceuticals GAAP EPS of -$0.06, revenue of $7.93M
Source: SeekingAlpha
2025-03-10 06:15:10 ET
More on Fennec Pharmaceuticals
- Fennec's Pedmarqsi gets nod from U.K. regulators
- Fennec Pharmaceuticals partially repays its outstanding convertible debt facility
- Seeking Alpha’s Quant Rating on Fennec Pharmaceuticals
- Historical earnings data for Fennec Pharmaceuticals
- Financial information for Fennec Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Fennec Pharmaceuticals GAAP EPS of -$0.06, revenue of $7.93M
Fennec Pharmaceuticals Inc.
NASDAQ: FENC
FENC Trading
15.39% G/L:
$10.12 Last:
170,533 Volume:
$9.29 Open:
FENC Latest News
May 14, 2026 06:30:00 am
Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business UpdateMay 07, 2026 06:36:00 am
Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026April 21, 2026 04:30:00 pm
Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual MeetingFENC Stock Data
$217,266,422
14,266,721
89.84%
25
N/A
Biotechnology & Life Sciences
Healthcare
US
Research Triangle Park
